BNF 84 (British National Formulary) September 2022-March 2023: 84: September 2022 - March 2023

Product Information

A British National Formulary (BNF) is a medical and pharmaceutical publication that contains information and advice on prescribing and pharmacology, along with specific facts and details about all medicines available on the NHS. We may be able to source and supply a paper copy in exceptional circumstances, from surplus BNFs distributed to other parts of the NHS. Please register your interest in receiving a copy via the online form at: https://www.snapsurveys.com/wh/s.asp?k=153553886772 Over the last year, we have undertaken research to understand how we could ensure that specialist drug content in BNF Publications is aligned with the stated scope within the preface, and with the primary use case of the BNF. Analytics around the use of BNF Publications’ content confirmed that specialist drug content is accessed much less frequently than drug content for non-specialist use. User research supported the analytics, and showed that those users who did access specialist content were most commonly looking at safety information, such as contra-indications, interactions, and side-effects. Paper copies were historically distributed yearly, each October. The digital versions will take over from this October 2018. Please note that co-trimoxazole currently has its own entry in print that does not include the interactions for trimethoprim. As stated above, it is essential to refer to both drugs (trimethoprim and sulfamethoxazole, under sulfonamides) to find all relevant interactions for this drug. This inconsistency will be corrected in the upcoming September editions, BNF 78 and BNF for Children 2019-2020. Digital products including MedicinesComplete and the BNF app have been corrected for the June monthly update.

Ibrutinib (Imbruvica®): new risk minimisation measures, including dose modification recommendations, due to the increased risk for serious cardiac eventsPharmaceutical Excipients: Properties, Functionality and Applications in Research and Industry (2017) Author (Year of publication) 'Title of chapter/section', in Title of reference source.Available at: URL (Accessed: date). Pre-treatment screening advice on genetic testing for aminoglycoside exposure posing risk to hearing Blood Results in Clinical Practice: A Practical Guide to Interpreting Blood Test Results - 2nd ed. (2019) Ideal for use by Pharmacists, Chemists, Nurses and Doctors within Hospitals, Nursing Homes, Pharmacies and Hospices and the ideal reference tool for all Care and support staff. See also:

Adrenaline/epinephrine: recall of Emerade® 500 micrograms and Emerade® 300 micrograms auto-injectors, due to the potential for device failure [National Patient Safety Alert advice] Pharmaceutical Preformulation and Formulation: a Practical Guide from Candidate Drug Selection to Commercial Dosage Form - 2nd ed. (2009) As noted in the British National Formulary (BNF) the recommended dosage for children under 12 is...(Joint Formulary Committee, 2021)." From June 2023, BNF Publications will be more clearly and consistently identifying specialist drug monographs within content, by including the words “Specialist drug” alongside the monograph title. This feature will be applied to existing monographs, and to monographs moving forward, that are used within specialist settings (such as drugs used for malignancy, and those given via intravitreal injection). These “specialist drug” monographs will contain less detail than a regular monograph within BNF Publications. A “specialist drug” monograph will continue to include information to support patient safety and non-specialist patient care (such as important safety information, interactions, side-effects, and contra-indications), but it will not contain information which is within the remit of specialist care (such as doses, and directions for administration). For some vaccines, such as the influenza vaccines, live and inactivated preparations are available, so information has been separated into two monographs. Users should ensure they are referring to the correct monograph when looking for information; to navigate between related monographs, use the cross-reference in the Drug action section.With the latest update, you now have access to the new features on the BNF app, providing you with an improved experience. The British National Formulary (BNF) is a book that is published twice a year in March and September. Compiled with the advice of clinical experts, its an essential reference providing up to date guidance on the prescribing, dispensing and administration of medicines. British National Formulary (BNF) Product Details: Vaccine monographs in the BNF and BNF for Children have been updated to more clearly identify whether a vaccine is live or not. Pholcodine-containing cough and cold medicines: withdrawal from UK market as a precautionary measure The vaccines class monograph has also been reviewed and updated. Information that is common to all vaccines can be found in the Vaccines, general class monograph. A new class monograph Vaccines, live contains information that is only relevant to live vaccines. Some monographs may have additional information that is specific to the individual vaccine. In such cases, information from the class monograph(s) and the individual monograph need to be considered together.

Specialist drug monographs: inclusion of the words “Specialist drug” alongside the monograph title to identify drugs used within specialist settings (such as drugs used for malignancy, and those given via intravitreal injection). These monographs continue to include information to support patient safety and non-specialist patient care (such as important safety information, interactions, side-effects, and contra-indications) but no longer include information which is within the remit of specialist care (such as doses, and directions for administration).

Comments (0)

An integral part of the UK’s healthcare infrastructure and relied on by health professionals who prescribe, dispense, and administer medicines globally. Containing guidance on best practice in prescribing, as well as legal and ethical considerations, BNF supports safe and effective decision-making at the point of care. Practical and evidence based, British National Formulary (BNF) is the only drug formulary in the world that is both independent, and has rigorous, accredited content creation processes. Physical Examination Procedures for Advanced Practitioners and Non-Medical Prescribers - 2nd ed. (2015)